Latest News

Date Title Topic
21 Oct 2014 Cancer Guides for Patients
Breast Cancer
02 Oct 2014 Rare Cancers Europe Press Release: Specific Clinical Trial Methodology Needed for Rare Cancers
30 Sep 2014 Is precision medicine coming of age? Personalised medicine
30 Sep 2014 ESMO 2014 Wrap-Up: What should be remembered?
30 Sep 2014 ESMO 2014: Pembrolizumab Shows Promise in Several Solid Tumours Genitourinary cancers - Translational research - Melanoma - Lung and other thoracic tumours - Head and neck cancers - Gastrointestinal cancers - Immuno-oncology
30 Sep 2014 Pathway of the Day: PI3K/AKT/mTOR Pathology/Molecular biology
30 Sep 2014 ESMO 2014 Press Release: Cancer Medicine Becoming Ever More Precise, Practice-Changing Results at ESMO 2014 Show
29 Sep 2014 Phase III trial data suggest potential new treatment strategies for prostate cancer Genitourinary cancers
29 Sep 2014 ESMO 2014: Pazopanib Improves Progression-Free Survival in Phase II Study in Patients with Advanced GIST Sarcomas - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Cobimetinib in Combination with Vemurafenib Improves PFS in BRAF-Mutant Unresectable Locally-Advanced or Metastatic Melanoma Personalised medicine - Melanoma - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Combination Dabrafenib/Trametinib Improves OS in Comparison with Vemurafenib in Patients With BRAF-Mutation Positive Melanoma Personalised medicine - Melanoma - Anticancer agents & Biologic therapy
29 Sep 2014 ESMO 2014: Results of a Phase III Randomised Study of Nivolumab in Patients with Advanced Melanoma After Prior Anti-CTLA4 Therapy Melanoma - Immuno-oncology